<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2017.6510</article-id>
<article-id pub-id-type="publisher-id">mmr-15-06-4280</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Role of ataxia-telangiectasia mutated in hydrogen peroxide preconditioning against oxidative stress in Neuro-2a cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Jianhua</given-names></name>
<xref rid="af1-mmr-15-06-4280" ref-type="aff">1</xref>
<xref rid="fn1-mmr-15-06-4280" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Fang</given-names></name>
<xref rid="af1-mmr-15-06-4280" ref-type="aff">1</xref>
<xref rid="fn1-mmr-15-06-4280" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Su</surname><given-names>Zhiqiang</given-names></name>
<xref rid="af2-mmr-15-06-4280" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Jue</given-names></name>
<xref rid="af3-mmr-15-06-4280" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Sang</given-names></name>
<xref rid="af1-mmr-15-06-4280" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Hao</given-names></name>
<xref rid="af1-mmr-15-06-4280" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Pei</given-names></name>
<xref rid="af1-mmr-15-06-4280" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Dongfang</given-names></name>
<xref rid="af1-mmr-15-06-4280" ref-type="aff">1</xref>
<xref rid="c1-mmr-15-06-4280" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-15-06-4280"><label>1</label>Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China</aff>
<aff id="af2-mmr-15-06-4280"><label>2</label>Department of Pharmacy, The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong 510405, P.R. China</aff>
<aff id="af3-mmr-15-06-4280"><label>3</label>Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-15-06-4280"><italic>Correspondence to</italic>: Professor Dongfang Wu, Department of Pharmacy, Zhongnan Hospital of Wuhan University, 169 Dong-Hu Road, Wuhan, Hubei 430071, P.R. China, E-mail: <email>dfwu2010@whu.edu.cn</email></corresp>
<fn id="fn1-mmr-15-06-4280"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub"><month>06</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>25</day><month>04</month><year>2017</year></pub-date>
<volume>15</volume>
<issue>6</issue>
<fpage>4280</fpage>
<lpage>4285</lpage>
<history>
<date date-type="received"><day>16</day><month>12</month><year>2015</year></date>
<date date-type="accepted"><day>27</day><month>01</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>Ischemic preconditioning is an endogenous protective mechanism that may be triggered by exposure to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). However, the exact mechanisms underlying preconditioning remain to be fully understood. Ataxia-telangiectasia mutated (ATM) is regarded as an essential endogenous protective protein against stress. The aim of the present study was therefore to investigate whether ATM mediates H<sub>2</sub>O<sub>2</sub> preconditioning. Preconditioning of Neuro-2a (N2a) cells with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 90 min resulted in protection from injury induced by a long period of exposure to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. In addition, preconditioning with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> activated ATM and increased ATM mRNA and protein expression levels in N2a cells. Furthermore, the protective effects induced by H<sub>2</sub>O<sub>2</sub> preconditioning were attenuated by pretreatment with the ATM inhibitor, Ku55933, or ATM small interfering RNA. In conclusion, these findings suggested that ATM is involved in H<sub>2</sub>O<sub>2</sub> preconditioning-mediated protection against oxidative stress-induced injury in N2a cells. To the best of our knowledge, the present study demonstrated, for the first time, that the ATM protein is a key mediator of H<sub>2</sub>O<sub>2</sub> preconditioning.</p>
</abstract>
<kwd-group>
<kwd>ataxia-telangiectasia mutated</kwd>
<kwd>preconditioning</kwd>
<kwd>hydrogen peroxide</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Ischemic preconditioning is an endogenous protective mechanism whereby tissue subject to single or multiple brief episodes of ischemia/reperfusion develops protection against subsequent potentially lethal ischemic injury. Previous studies have demonstrated that preconditioning is additionally triggered by non-ischemic stress, including exposure to reactive oxygen species (ROS) (<xref rid="b1-mmr-15-06-4280" ref-type="bibr">1</xref>,<xref rid="b2-mmr-15-06-4280" ref-type="bibr">2</xref>). However, the exact mechanisms underlying preconditioning remain to be fully understood.</p>
<p>Ataxia-telangiectasia mutated (ATM) serine/threonine kinase is a member of a superfamily of phosphatidylinositol (PI) 3-kinase-like kinases (<xref rid="b3-mmr-15-06-4280" ref-type="bibr">3</xref>) and is regarded as a lynchpin of cellular defenses to stress, particularly antioxidative stress, maintaining cellular redox homeostasis (<xref rid="b4-mmr-15-06-4280" ref-type="bibr">4</xref>). Previous studies have reported that ATM-deficient mice have increased levels of ROS, particularly in the nervous system, leading to neuronal degeneration (<xref rid="b5-mmr-15-06-4280" ref-type="bibr">5</xref>,<xref rid="b6-mmr-15-06-4280" ref-type="bibr">6</xref>). In addition, it has been reported that activation of ATM in the cytoplasm protects neurons against oxidative stress-induced damage (<xref rid="b7-mmr-15-06-4280" ref-type="bibr">7</xref>). Patients with ataxia telangiectasia, carrying mutations at the two ATM alleles (ATM<sup>&#x2212;</sup>/<sup>&#x2212;</sup>), present with progressive cerebellar ataxia and cerebellar degeneration (<xref rid="b8-mmr-15-06-4280" ref-type="bibr">8</xref>,<xref rid="b9-mmr-15-06-4280" ref-type="bibr">9</xref>). There is accumulating evidence to suggest that ATM is a central regulator of the response to DNA damage, including DNA repair, telomere maintenance and regulation of the cell cycle (<xref rid="b10-mmr-15-06-4280" ref-type="bibr">10</xref>&#x2013;<xref rid="b12-mmr-15-06-4280" ref-type="bibr">12</xref>). Although ATM is expressed in the brain and neurons (<xref rid="b13-mmr-15-06-4280" ref-type="bibr">13</xref>), its involvement in preconditioning remains to be investigated. The present study investigated whether H<sub>2</sub>O<sub>2</sub> preconditioning protected against injury induced by oxidative stress in Neuro-2a (N2a) cells, and the role of ATM in H<sub>2</sub>O<sub>2</sub> preconditioning.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cell culture and treatment</title>
<p>N2a mouse neuroblast cells (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) were cultured in high-Dulbecco&#x0027;s modified Eagle&#x0027;s medium/OPTI-Minimal Essential Medium (1:1; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 5&#x0025; (v/v) fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) in a humidified atmosphere of 5&#x0025; CO<sub>2</sub> at 37&#x00B0;C. Cells were passaged by trypsinization and seeded at ~10<sup>5</sup> cells/ml. When cells reached 60&#x2013;80&#x0025; confluence, the culture medium was replaced with serum-free medium for 12&#x2013;24 h. Cells were initially treated with 20, 50, 100, 300, 600 and 1,000 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h to assess the effect of different doses of H<sub>2</sub>O<sub>2</sub> on N2a cell viability. The results of this treatment indicated that 600 uM H<sub>2</sub>O<sub>2</sub> was the median lethal dose. Therefore, 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> was used for subsequent experiments. Subsequently, cells were pretreated with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 90 min followed by 12 h recovery and subsequent exposure to the median lethal dose of 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h. To evaluate the involvement of ATM in preconditioning-induced protection, additional experiments were performed. N2a cells were treated with 10 &#x00B5;M ATM-specific inhibitor Ku55933 (Sigma-Aldrich; Merck KGaA) for 30 min or transfected with ATM small interfering RNA (siRNA) for 36 h prior to H<sub>2</sub>O<sub>2</sub> preconditioning. Following H<sub>2</sub>O<sub>2</sub> preconditioning, these cells were subjected to the lethal dose of 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>.</p>
</sec>
<sec>
<title>Assessment of cell viability</title>
<p>An MTT assay was used to determine cell viability. N2a cells were seeded at a density of 1&#x00D7;10<sup>4</sup> cells/well in a 96-well culture plate. At the end of each experiment, 10 &#x00B5;l MTT (0.5 mg/ml) was added to the cell medium and incubated for 4 h at 37&#x00B0;C. Following incubation, MTT solutions were removed, dimethyl sulfoxide was added, and the absorbance at 490 nm was measured using a microplate reader. Data are expressed as a percentage of the control, which was considered to be 100&#x0025; viable.</p>
</sec>
<sec>
<title>siRNA transfection</title>
<p>N2a cells were transfected with 50 nM ATM siRNA or Scramble control siRNA using Lipofectamine 2000<sup>&#x00AE;</sup> reagent (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer&#x0027;s protocol. The siRNA sequences utilized targeted the following mouse ATM coding sequence: 5&#x2032;-GCTTGAGGCTGATCCATATTC-3&#x2032;. To determine the effect of siRNA transfection, the N2a cells were collected and lysed with lysis buffer [50 mM NaCl, 10 mM Tris-base, 1 mM EDTA, 2 mM sodium orthovanadate (Na<sub>3</sub>VO<sub>4</sub>), 1 mM NaF, 1 mM phenylmethyl-sulfonyl fluoride, 1&#x0025; sodium dodecyl sulfate (SDS)] at 95&#x00B0;C for 10 min for western blot analysis 48 h following transfection.</p>
</sec>
<sec>
<title>RT-qPCR</title>
<p>Total cellular RNA was isolated using TRIzol<sup>&#x00AE;</sup> reagent (Invitrogen; Thermo Fisher Scientific, Inc.) and cDNA was generated from 1 &#x00B5;g total RNA using the M-MLV reverse transcription kit (Promega Corporation, Madison, WI, USA). Quantification of gene copies was performed using the ABI 7300 Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.) with the Power SYBR<sup>&#x00AE;</sup> Green PCR Master Mix kit (Promega Corporation). The primer sequences used were as follows: Forward, 5&#x2032;-GCACACGGATTGCTCAAGGA-3&#x2032; and reverse, 5&#x2032;-GCCCATTCGGAATATGGATCAG-3&#x2032; for ATM (<xref rid="b14-mmr-15-06-4280" ref-type="bibr">14</xref>); and forward, 5&#x2032;-CAATGACCCCTTCATTGA-3&#x2032; and reverse, 5&#x2032;-GACAAGCTTCCCGTTCTCAG-3&#x2032; for GAPDH (<xref rid="b15-mmr-15-06-4280" ref-type="bibr">15</xref>). The following thermocycling conditions were used: An initial predenaturation step at 95&#x00B0;C for 10 min, followed by 40 cycles of denaturation at 95&#x00B0;C for 15 sec and annealing at 60&#x00B0;C for 60 sec. All amplification reactions for each sample were repeated in at least triplicate, and the relative expression values were normalized to those of GAPDH using the 2<sup>&#x2212;&#x0394;&#x0394;Cq</sup> method (<xref rid="b16-mmr-15-06-4280" ref-type="bibr">16</xref>).</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>Cells were lysed with lysis buffer [50 mM NaCl, 10 mM Tris-base, 1 mM EDTA, 2 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM NaF, 1 mM phenylmethyl-sulfonyl fluoride, 1&#x0025; SDS], and the protein content of the lysates was measured using the bicinchoninic acid assay. Subsequently, 40 &#x00B5;g/lane protein was separated by 7.0&#x0025; SDS-polyacrylamide gel electrophoresis and electrophoretically transferred to a nitrocellulose membrane. The membranes were blocked with 5&#x0025; bovine serum albumin (Beyotime Institute of Biotechnology, Haimen, China) in TBS containing 1&#x0025; Tween 20 at room temperature for 1 h, and incubated with ATM (mouse monoclonal antibody; dilution, 1:1,000; cat. no. sc-47739; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), phosphorylated (p)-ATM antibodies (mouse monoclonal antibody; dilution, 1:500; cat. no. sc-73615; Santa Cruz Biotechnology, Inc.) and &#x03B2;-actin (rabbit polyclonal antibody; dilution, 1:1,000; cat. no. sc-130656; Santa Cruz Biotechnology, Inc.) at 4&#x00B0;C overnight, followed by incubation with a horseradish peroxidase-conjugated secondary antibody (either goat anti-rabbit; dilution, 1:1,000; cat. no. A0208. Or goat anti-mouse; dilution, 1:1,000; cat. no. A0216; Beyotime Institute of Biotechnology) for 1 h at room temperature. The immunostaining was visualized by enhanced chemiluminescence (Beyotime Institute of Biotechnology). The blots were scanned, and the pixel count and intensity of each band was quantified using the Scion Image software (version 4.2.3.2; Scion Corporation, Frederick, MD, USA). The results were normalized to &#x03B2;-actin expression.</p>
</sec>
<sec>
<title>Flow cytometric analysis of apoptosis</title>
<p>Flow cytometry was performed as described in a previous study by Tang <italic>et al</italic> (<xref rid="b1-mmr-15-06-4280" ref-type="bibr">1</xref>). Briefly, treated N2a cells (2&#x00D7;10<sup>6</sup>) were collected and centrifuged at 5,000 &#x00D7; <italic>g</italic> at 4&#x00B0;C for 10 min. The cell pellet was resuspended in cold PBS and fixed using 70&#x0025; ethanol at 4&#x00B0;C for 1 h. The cells were then centrifuged at 5,000 &#x00D7; <italic>g</italic> for 10 min, and resuspended in PBS. DNase-free RNaseA (100 &#x00B5;l, 200 &#x00B5;g/ml) was added to the cells and incubated at 37&#x00B0;C for 10 min. Cells were subsequently incubated with propidium iodide (PI) at a final concentration of 100 mg/l, filtered and incubated in the dark at room temperature for 10 min prior to flow cytometric analysis. The PI fluorescence of individual nuclei was measured using a flow cytometer (Beckman-Coulter, Inc., Brea, CA, USA). DNA labeling data were analyzed using CellQuest v.3.0 sampling software (BD Biosciences, Franklin, NJ, USA) for flow cytometry.</p>
</sec>
<sec>
<title>Caspase-3 activity assay</title>
<p>Caspase-3 activity was measured using a colorimetric CaspACE kit (Promega Corporation) according to the manufacturer&#x0027;s protocol. Cells were lysed using the kit lysis buffer (Promega Corporation) and centrifuged for 5 min at 5,000 &#x00D7; <italic>g</italic> and 4&#x00B0;C. The supernatant was used for the measurement of caspase-3 activity.</p>
</sec>
<sec>
<title>Determination of 8-hydroxy-2&#x2032;-deoxyguanosine (8-OHdG) in DNA</title>
<p>DNA was extracted from N2a cells with the DNA Extractor kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan) according to the manufacturer&#x0027;s protocol. The extracted DNA was digested with 8 units nuclease P1 (Cell Biolabs, Inc., San Diego, CA, USA) for 2 h at 37&#x00B0;C in a final concentration of 20 mM sodium acetate (pH 5.2), followed by treatment of 6 units alkaline phosphatase for 1 h at 37&#x00B0;C in a final concentration of 100 mM Tris (pH 7.5). The reaction mixture was centrifuged for 5 min at 6,000 &#x00D7; <italic>g</italic> and 4&#x00B0;C, and the supernatant was used for the 8-OHdG Quantitation ELISA assay (catalog no. STA-320; Cell Biolabs, Inc.), according to the manufacturer&#x0027;s protocol.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>SPSS statistical software was used for statistical analysis (version 18.0; SPSS, Inc., Chicago, IL, USA). The data are expressed as the mean &#x00B1; standard error of at least 3 replicate experiments. Comparisons among multiple groups were performed using one-way analysis of variance followed by the Student-Newman-Keuls post hoc test. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Effect of H<sub>2</sub>O<sub>2</sub> preconditioning on cell viability following oxidative stress</title>
<p>The effect of different concentrations of H<sub>2</sub>O<sub>2</sub> on N2a cell viability was evaluated by MTT assay (<xref rid="f1-mmr-15-06-4280" ref-type="fig">Fig. 1</xref>). Treatment with 20&#x2013;100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> did not significantly affect N2a cell viability; however, concentrations of 300, 600 and 1,000 &#x00B5;M significantly decreased N2a cell viability compared with the control, to 78.5&#x00B1;6.5 (P&#x003C;0.05), 44.2&#x00B1;3.5 (P&#x003C;0.01) and 11.4&#x00B1;1.4&#x0025; (P&#x003C;0.001), respectively. In addition, an MTT assay demonstrated that preconditioning cells with 50 or 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> attenuated the reduction of N2a cell viability induced by 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, compared with the non-preconditioned group (P&#x003C;0.05 and P&#x003C;0.01, respectively; <xref rid="f2-mmr-15-06-4280" ref-type="fig">Fig. 2</xref>), with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> most effective. Preconditioning with 20 &#x00B5;M H<sub>2</sub>O<sub>2</sub> failed to significantly attenuate the reduction in cell viability induced by treatment with 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> (P&#x003E;0.05; <xref rid="f2-mmr-15-06-4280" ref-type="fig">Fig. 2</xref>). Therefore, 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> was selected for preconditioning in subsequent experiments.</p>
</sec>
<sec>
<title>H<sub>2</sub>O<sub>2</sub> preconditioning decreases neuronal apoptosis, caspase-3 activity and 8-OHdG content</title>
<p>Following exposure of N2a cells to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 12 h, the percentage of apoptotic N2a cells increased significantly compared with the control (62.8&#x00B1;5.2 vs. 6.5&#x00B1;0.5&#x0025;; P&#x003C;0.01; <xref rid="f3-mmr-15-06-4280" ref-type="fig">Fig. 3</xref>). Preconditioning with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 90 min did not significantly alter the apoptotic rate compared with the control (9.5&#x00B1;0.89 vs. 6.5&#x00B1;0.5&#x0025;; n=5; P&#x003E;0.05; <xref rid="f3-mmr-15-06-4280" ref-type="fig">Fig. 3</xref>); however, subsequent 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>-induced apoptosis was significantly inhibited following preconditioning compared with the non-preconditioned group (33.8&#x00B1;3.1 vs. 62.8&#x00B1;5.2&#x0025;, respectively; n=5; P&#x003C;0.01; <xref rid="f3-mmr-15-06-4280" ref-type="fig">Fig. 3</xref>).</p>
<p>The caspase 3 protein is a member of the cysteine-aspartic acid protease (caspase) family (<xref rid="b17-mmr-15-06-4280" ref-type="bibr">17</xref>). Sequential activation of caspases serves a central role in the execution-phase of cell apoptosis, thus caspase-3 activity is a marker of cell apoptosis (<xref rid="b18-mmr-15-06-4280" ref-type="bibr">18</xref>). Consistent with the results of flow cytometric analysis, caspase-3 activity was significantly decreased in N2a cells preconditioned with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> and exposed to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> compared with the non-preconditioned group (P&#x003C;0.01; <xref rid="f4-mmr-15-06-4280" ref-type="fig">Fig. 4</xref>).</p>
<p>8-OHdG is a marker of oxidative stress (<xref rid="b19-mmr-15-06-4280" ref-type="bibr">19</xref>). The present study observed that 8-OHdG content was additionally significantly decreased in N2a cells preconditioned with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> and exposed to 600 &#x00B5;MH<sub>2</sub>O<sub>2</sub> compared with the non-preconditioned group (P&#x003C;0.01; <xref rid="f5-mmr-15-06-4280" ref-type="fig">Fig. 5</xref>).</p>
</sec>
<sec>
<title>Effect of H<sub>2</sub>O<sub>2</sub> preconditioning on ATM expression</title>
<p>The effect of 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> preconditioning on ATM mRNA and protein expression levels was determined. Preconditioning of N2a cells with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 90 min significantly increased p-ATM protein expression levels compared with the control (P&#x003C;0.01; <xref rid="f6-mmr-15-06-4280" ref-type="fig">Fig. 6</xref>). Preconditioning with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 90 min, then 12 h later, increased the expression of ATM mRNA and protein when compared with the control (P&#x003C;0.01; <xref rid="f7-mmr-15-06-4280" ref-type="fig">Fig. 7A and B</xref>).</p>
</sec>
<sec>
<title>ATM inhibition or knockdown attenuates the protective effect of H<sub>2</sub>O<sub>2</sub> preconditioning</title>
<p>To determine the involvement of ATM in H<sub>2</sub>O<sub>2</sub> preconditioning, RNA interference (RNAi) with siRNA, and treatment with an ATM inhibitor, was performed. siRNA-mediated knockdown of ATM resulted in reduction of ATM protein expression compared with the untransfected control and scramble control groups (P&#x003C;0.01; <xref rid="f8-mmr-15-06-4280" ref-type="fig">Fig. 8</xref>). When N2a cells were incubated with 10 &#x00B5;mol/l Ku55933 for 36 h or transfected with 50 nM control siRNA, the percentage of apoptotic cells was 8.0&#x00B1;0.68 and 11.1&#x00B1;0.96&#x0025;, respectively, and were not significantly different compared with the control group (6.5&#x00B1;0.5&#x0025;; P&#x003E;0.05; <xref rid="f3-mmr-15-06-4280" ref-type="fig">Fig. 3</xref>). However, the anti-apoptotic effect of preconditioning with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> was decreased by pretreatment with the ATM inhibitor Ku55933 or silencing of ATM with RNAi compared with the preconditioned group (P&#x003C;0.01 and P&#x003C;0.01, respectively; <xref rid="f3-mmr-15-06-4280" ref-type="fig">Fig. 3</xref>). In addition, the decreased caspase-3 activity observed following preconditioning with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> was inhibited by the pretreatment of cells with the ATM inhibitor Ku55933 or silencing of ATM with RNAi compared with the preconditioned group (P&#x003C;0.01 and P&#x003C;0.01, respectively; <xref rid="f4-mmr-15-06-4280" ref-type="fig">Fig. 4</xref>) and the decrease in 8-OHdG content observed following preconditioning with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub> was also inhibited by pretreatment with the ATM inhibitor Ku55933 or silencing of ATM with RNAi compared with the preconditioned group (P&#x003C;0.01 and P&#x003C;0.01, respectively; <xref rid="f5-mmr-15-06-4280" ref-type="fig">Fig. 5</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The results of the present study revealed that H<sub>2</sub>O<sub>2</sub> preconditioning protects N2a cells against oxidative stress-induced injury, H<sub>2</sub>O<sub>2</sub> preconditioning upregulates ATM mRNA and protein expression levels, and pretreatment with an ATM inhibitor or knockdown of ATM abrogates the protective effects of H<sub>2</sub>O<sub>2</sub> preconditioning against lethal H<sub>2</sub>O<sub>2</sub>-induced cell injury. This demonstrated that ATM may mediate the protective effects of H<sub>2</sub>O<sub>2</sub> preconditioning.</p>
<p>Oxidative stress induced by ROS is a primary cause of ischemia/reperfusion injury; however, previous studies have reported that ROS generated from brief ischemia/reperfusion events triggers preconditioning-like protection. Brief exposure to exogenous oxygen species protected PC12 cells and neurons against subsequent serious oxidative stress injury via opening of surface K<sub>ATP</sub> channels (<xref rid="b20-mmr-15-06-4280" ref-type="bibr">20</xref>), increasing expression of Bcl-2 (<xref rid="b1-mmr-15-06-4280" ref-type="bibr">1</xref>) and hypoxia-inducible factor-1&#x03B1; protein (<xref rid="b21-mmr-15-06-4280" ref-type="bibr">21</xref>), or enhancing the expression and functional activities of volume-activated chloride channels (<xref rid="b22-mmr-15-06-4280" ref-type="bibr">22</xref>). The present study observed that H<sub>2</sub>O<sub>2</sub> preconditioning protected against oxidative stress-induced injury in N2a cells, as assessed by MTT assays, flow cytometry, and analysis of capase-3 activity and 8-OHdG content.</p>
<p>Although numerous previous studies have been performed, the cellular and molecular mechanisms underlying preconditioning remain to be fully clarified. A previous study reported that activation of ATM regulates cell redox homeostasis in various w ays, including the enhancement of glucose-6-phosphate dehydrogenase activity, thereby increasing the intracellular nicotinamide adenine dinucleotide phosphate and glutathione content significantly (<xref rid="b10-mmr-15-06-4280" ref-type="bibr">10</xref>). ATM-deficient lymphoid stem cells exhibit mitochondrial dysfunction and a significant increase in ROS; exogenous ATM restores mitochondrial function and reduces the generation of ROS (<xref rid="b23-mmr-15-06-4280" ref-type="bibr">23</xref>). ATM is additionally present in the peroxisomes, regulating catalase activity (<xref rid="b24-mmr-15-06-4280" ref-type="bibr">24</xref>). Previous studies have reported that when PC12 cells or neurons were subjected to metabolic stress including serum starvation, ATM regulated the insulin-associated signaling pathway and inhibited neuronal apoptosis (<xref rid="b25-mmr-15-06-4280" ref-type="bibr">25</xref>,<xref rid="b26-mmr-15-06-4280" ref-type="bibr">26</xref>). In addition, a previous study indicated that histone acetyltransferase 4 accumulates more readily in the nuclei of ATM-deficient neurons, and inhibits myocyte enhancer factor 2A/cyclic adenosine monophosphate response element binding-dependent transcription to promote neurodegeneration (<xref rid="b27-mmr-15-06-4280" ref-type="bibr">27</xref>). Based on these findings, ATM is regarded as an essential endogenous protective protein against stress (<xref rid="b4-mmr-15-06-4280" ref-type="bibr">4</xref>).</p>
<p>As the preconditioning process induces endogenous protective mechanisms, it was hypothesized that ATM may be involved in H<sub>2</sub>O<sub>2</sub> preconditioning. Therefore, the effect of H<sub>2</sub>O<sub>2</sub> preconditioning on the expression levels of ATM was measured. Notably, H<sub>2</sub>O<sub>2</sub> preconditioning was observed to increase the protein expression levels of p-ATM, which indicated that H<sub>2</sub>O<sub>2</sub> preconditioning activated ATM. Following H<sub>2</sub>O<sub>2</sub> preconditioning for 12 h, ATM mRNA and protein expression levels increased, which supported this hypothesis. Additionally, the ATM inhibitor Ku55933, or knockdown of ATM using RNAi, attenuated the protective effect of H<sub>2</sub>O<sub>2</sub> preconditioning against oxidative stress-induced injury. These data suggested that ATM is involved in H<sub>2</sub>O<sub>2</sub> preconditioning.</p>
<p>In conclusion, the results of the present study demonstrated, to the best of our knowledge for the first time, that H<sub>2</sub>O<sub>2</sub> preconditioning activates ATM and upregulates ATM mRNA and protein expression levels in N2a cells. Treatment with the ATM inhibitor, Ku55933, or silencing of ATM with RNAi attenuated the protective effect of H<sub>2</sub>O<sub>2</sub> preconditioning in N2a cells. These results provide insight into the mechanisms underlying the involvement of ATM in H<sub>2</sub>O<sub>2</sub> preconditioning. In addition, the present study highlights the potential of the ATM protein as a key therapeutic target for the prevention and treatment of ischemic brain damage.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by the National Nature Science Foundation of China (grant no. 81301057 to J.H.W. and grant no. 30971428 to D.F.W), the Foundation of Health and Family Planning Commission of Hubei province (grant no. WJ2015MB029 to D.F.W) and the Chenguang Plan of Wuhan Municipal Science and Technology Bureau (grant no. 2014070404010226 to J.L.).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-15-06-4280"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>XQ</given-names></name><name><surname>Feng</surname><given-names>JQ</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>PX</given-names></name><name><surname>Zhi</surname><given-names>JL</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>RX</given-names></name><name><surname>Yu</surname><given-names>HM</given-names></name></person-group><article-title>Protection of oxidative preconditioning against apoptosis induced by H2O2 in PC12 cells: Mechanisms via MMP, ROS, and Bcl-2</article-title><source>Brain Res</source><volume>1057</volume><fpage>57</fpage><lpage>64</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.brainres.2005.07.072</pub-id></element-citation></ref>
<ref id="b2-mmr-15-06-4280"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x00F3;n</surname><given-names>OS</given-names></name><name><surname>Men&#x00E9;ndez</surname><given-names>S</given-names></name><name><surname>Merino</surname><given-names>N</given-names></name><name><surname>Castillo</surname><given-names>R</given-names></name><name><surname>Sam</surname><given-names>S</given-names></name><name><surname>P&#x00E9;rez</surname><given-names>L</given-names></name><name><surname>Cruz</surname><given-names>E</given-names></name><name><surname>Bocci</surname><given-names>V</given-names></name></person-group><article-title>Ozone oxidative preconditioning: A protection against cellular damage by free radicals</article-title><source>Mediators Inflamm</source><volume>7</volume><fpage>289</fpage><lpage>294</lpage><year>1998</year><pub-id pub-id-type="doi">10.1080/09629359890983</pub-id><pub-id pub-id-type="pmcid">1781855</pub-id></element-citation></ref>
<ref id="b3-mmr-15-06-4280"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiloh</surname><given-names>Y</given-names></name></person-group><article-title>ATM and related protein kinases: Safeguarding genome integrity</article-title><source>Nat Rev Cancer</source><volume>3</volume><fpage>155</fpage><lpage>168</lpage><year>2003</year><pub-id pub-id-type="doi">10.1038/nrc1011</pub-id></element-citation></ref>
<ref id="b4-mmr-15-06-4280"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatti</surname><given-names>S</given-names></name><name><surname>Kozlov</surname><given-names>S</given-names></name><name><surname>Farooqi</surname><given-names>AA</given-names></name><name><surname>Naqi</surname><given-names>A</given-names></name><name><surname>Lavin</surname><given-names>M</given-names></name><name><surname>Khanna</surname><given-names>KK</given-names></name></person-group><article-title>ATM protein kinase: The linchpin of cellular defenses to stress</article-title><source>Cell Mol Life Sci</source><volume>68</volume><fpage>2977</fpage><lpage>3006</lpage><year>2011</year><pub-id pub-id-type="doi">10.1007/s00018-011-0683-9</pub-id></element-citation></ref>
<ref id="b5-mmr-15-06-4280"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Ajmo</surname><given-names>JM</given-names></name><name><surname>Scofield</surname><given-names>VL</given-names></name><name><surname>Stoica</surname><given-names>G</given-names></name><name><surname>Wong</surname><given-names>PK</given-names></name></person-group><article-title>Activation of AMP-activated protein kinase in cerebella of Atm-/-mice is attributable to accumulation of reactive oxygen species</article-title><source>Biochem Biophys Res Commun</source><volume>418</volume><fpage>267</fpage><lpage>272</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.01.008</pub-id><pub-id pub-id-type="pmcid">4109361</pub-id></element-citation></ref>
<ref id="b6-mmr-15-06-4280"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamsler</surname><given-names>A</given-names></name><name><surname>Daily</surname><given-names>D</given-names></name><name><surname>Hochman</surname><given-names>A</given-names></name><name><surname>Stern</surname><given-names>N</given-names></name><name><surname>Shiloh</surname><given-names>Y</given-names></name><name><surname>Rotman</surname><given-names>G</given-names></name><name><surname>Barzilai</surname><given-names>A</given-names></name></person-group><article-title>Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice</article-title><source>Cancer Res</source><volume>61</volume><fpage>1849</fpage><lpage>1854</lpage><year>2001</year></element-citation></ref>
<ref id="b7-mmr-15-06-4280"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Kawaguchi</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>CG</given-names></name><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Shibamoto</surname><given-names>Y</given-names></name><name><surname>Lavin</surname><given-names>MF</given-names></name><name><surname>Khanna</surname><given-names>KK</given-names></name><name><surname>Miura</surname><given-names>Y</given-names></name></person-group><article-title>The ZFHX3 (ATBF1) transcription factor induces PDGFRB, which activates ATM in the cytoplasm to protect cerebellar neurons from oxidative stress</article-title><source>Dis Model Mech</source><volume>3</volume><fpage>752</fpage><lpage>762</lpage><year>2010</year><pub-id pub-id-type="doi">10.1242/dmm.004689</pub-id></element-citation></ref>
<ref id="b8-mmr-15-06-4280"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frappart</surname><given-names>PO</given-names></name><name><surname>McKinnon</surname><given-names>PJ</given-names></name></person-group><article-title>Ataxia-telangiectasia and related diseases</article-title><source>Neuromolecular Med</source><volume>8</volume><fpage>495</fpage><lpage>511</lpage><year>2006</year><pub-id pub-id-type="doi">10.1385/NMM:8:4:495</pub-id></element-citation></ref>
<ref id="b9-mmr-15-06-4280"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoche</surname><given-names>F</given-names></name><name><surname>Seidel</surname><given-names>K</given-names></name><name><surname>Theis</surname><given-names>M</given-names></name><name><surname>Vlaho</surname><given-names>S</given-names></name><name><surname>Schubert</surname><given-names>R</given-names></name><name><surname>Zielen</surname><given-names>S</given-names></name><name><surname>Kieslich</surname><given-names>M</given-names></name></person-group><article-title>Neurodegeneration in ataxia telangiectasia: What is new?</article-title><source>What is evident? Neuropediatrics</source><volume>43</volume><fpage>119</fpage><lpage>129</lpage><year>2012</year></element-citation></ref>
<ref id="b10-mmr-15-06-4280"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosentino</surname><given-names>C</given-names></name><name><surname>Grieco</surname><given-names>D</given-names></name><name><surname>Costanzo</surname><given-names>V</given-names></name></person-group><article-title>ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair</article-title><source>EMBO J</source><volume>30</volume><fpage>546</fpage><lpage>555</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/emboj.2010.330</pub-id></element-citation></ref>
<ref id="b11-mmr-15-06-4280"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobbin</surname><given-names>MM</given-names></name><name><surname>Madabhushi</surname><given-names>R</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Ahanonu</surname><given-names>B</given-names></name><name><surname>Pao</surname><given-names>PC</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name></person-group><article-title>SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons</article-title><source>Nat Neurosci</source><volume>16</volume><fpage>1008</fpage><lpage>1015</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nn.3460</pub-id><pub-id pub-id-type="pmcid">4758134</pub-id></element-citation></ref>
<ref id="b12-mmr-15-06-4280"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khanna</surname><given-names>KK</given-names></name><name><surname>Lavin</surname><given-names>MF</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name><name><surname>Mulhern</surname><given-names>TD</given-names></name></person-group><article-title>ATM, a central controller of cellular responses to DNA damage</article-title><source>Cell Death Differ</source><volume>8</volume><fpage>1052</fpage><lpage>1065</lpage><year>2001</year><pub-id pub-id-type="doi">10.1038/sj.cdd.4400874</pub-id></element-citation></ref>
<ref id="b13-mmr-15-06-4280"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ditch</surname><given-names>S</given-names></name><name><surname>Paull</surname><given-names>TT</given-names></name></person-group><article-title>The ATM protein kinase and cellular redox signaling: Beyond the DNA damage response</article-title><source>Trends Biochem Sci</source><volume>37</volume><fpage>15</fpage><lpage>22</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.tibs.2011.10.002</pub-id></element-citation></ref>
<ref id="b14-mmr-15-06-4280"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>MJ</given-names></name><name><surname>Wang</surname><given-names>WW</given-names></name><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Shen</surname><given-names>Q</given-names></name><name><surname>Min</surname><given-names>R</given-names></name></person-group><article-title>Radiation dose effect of DNA repair-related gene expression in mouse white blood cells</article-title><source>Med Sci Monit</source><volume>17</volume><fpage>BR290</fpage><lpage>BR297</lpage><year>2011</year><pub-id pub-id-type="doi">10.12659/MSM.881976</pub-id><pub-id pub-id-type="pmcid">3539470</pub-id></element-citation></ref>
<ref id="b15-mmr-15-06-4280"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JZ</given-names></name><name><surname>Wu</surname><given-names>JH</given-names></name><name><surname>Yu</surname><given-names>SY</given-names></name><name><surname>Shao</surname><given-names>QR</given-names></name><name><surname>Dong</surname><given-names>XM</given-names></name></person-group><article-title>Inhibitory effects of paeoniflorin on lysophosphatidylcholine-induced inflammatory factor production in human umbilical vein endothelial cells</article-title><source>Int J Mol Med</source><volume>31</volume><fpage>493</fpage><lpage>497</lpage><year>2013</year></element-citation></ref>
<ref id="b16-mmr-15-06-4280"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(&#x2212;Delta Delta C(T)) Method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></element-citation></ref>
<ref id="b17-mmr-15-06-4280"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alnemri</surname><given-names>ES</given-names></name><name><surname>Livingston</surname><given-names>DJ</given-names></name><name><surname>Nicholson</surname><given-names>DW</given-names></name><name><surname>Salvesen</surname><given-names>G</given-names></name><name><surname>Thornberry</surname><given-names>NA</given-names></name><name><surname>Wong</surname><given-names>WW</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Human ICE/CED-3 protease nomenclature</article-title><source>Cell</source><volume>87</volume><fpage>171</fpage><year>1996</year><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81334-3</pub-id></element-citation></ref>
<ref id="b18-mmr-15-06-4280"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghavami</surname><given-names>S</given-names></name><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Ande</surname><given-names>SR</given-names></name><name><surname>Yeganeh</surname><given-names>B</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Eshraghi</surname><given-names>M</given-names></name><name><surname>Bus</surname><given-names>CJ</given-names></name><name><surname>Kadkhoda</surname><given-names>K</given-names></name><name><surname>Wiechec</surname><given-names>E</given-names></name><name><surname>Halayko</surname><given-names>AJ</given-names></name><name><surname>Los</surname><given-names>M</given-names></name></person-group><article-title>Apoptosis and cancer: Mutations within caspase genes</article-title><source>J Med Genet</source><volume>46</volume><fpage>497</fpage><lpage>510</lpage><year>2009</year><pub-id pub-id-type="doi">10.1136/jmg.2009.066944</pub-id></element-citation></ref>
<ref id="b19-mmr-15-06-4280"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Komine-Kobayashi</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Urabe</surname><given-names>T</given-names></name></person-group><article-title>Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain</article-title><source>Stroke</source><volume>36</volume><fpage>2220</fpage><lpage>2225</lpage><year>2005</year><pub-id pub-id-type="doi">10.1161/01.STR.0000182241.07096.06</pub-id></element-citation></ref>
<ref id="b20-mmr-15-06-4280"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>XQ</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>EH</given-names></name><name><surname>Feng</surname><given-names>JQ</given-names></name><name><surname>Chen</surname><given-names>PX</given-names></name></person-group><article-title>Hydrogen peroxide preconditioning protects PC12 cells against apoptosis induced by oxidative stress</article-title><source>Sheng Li Xue Bao</source><volume>57</volume><fpage>211</fpage><lpage>216</lpage><year>2005</year></element-citation></ref>
<ref id="b21-mmr-15-06-4280"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Ferriero</surname><given-names>DM</given-names></name></person-group><article-title>Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons</article-title><source>Neurosci Lett</source><volume>441</volume><fpage>134</fpage><lpage>138</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.neulet.2008.08.090</pub-id><pub-id pub-id-type="pmcid">2518123</pub-id></element-citation></ref>
<ref id="b22-mmr-15-06-4280"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zuo</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Involvement of volume-activated chloride channels in H2O2 preconditioning against oxidant-induced injury through modulating cell volume regulation mechanisms and membrane permeability in PC12 cells</article-title><source>Mol Neurobiol</source><volume>48</volume><fpage>205</fpage><lpage>216</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s12035-013-8431-9</pub-id></element-citation></ref>
<ref id="b23-mmr-15-06-4280"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrose</surname><given-names>M</given-names></name><name><surname>Goldstine</surname><given-names>JV</given-names></name><name><surname>Gatti</surname><given-names>RA</given-names></name></person-group><article-title>Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells</article-title><source>Hum Mol Genet</source><volume>16</volume><fpage>2154</fpage><lpage>2164</lpage><year>2007</year><pub-id pub-id-type="doi">10.1093/hmg/ddm166</pub-id></element-citation></ref>
<ref id="b24-mmr-15-06-4280"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watters</surname><given-names>D</given-names></name><name><surname>Kedar</surname><given-names>P</given-names></name><name><surname>Spring</surname><given-names>K</given-names></name><name><surname>Bjorkman</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Gatei</surname><given-names>M</given-names></name><name><surname>Birrell</surname><given-names>G</given-names></name><name><surname>Garrone</surname><given-names>B</given-names></name><name><surname>Srinivasa</surname><given-names>P</given-names></name><name><surname>Crane</surname><given-names>DI</given-names></name><name><surname>Lavin</surname><given-names>MF</given-names></name></person-group><article-title>Localization of a portion of extranuclear ATM to peroxisomes</article-title><source>J Biol Chem</source><volume>274</volume><fpage>34277</fpage><lpage>34282</lpage><year>1999</year><pub-id pub-id-type="doi">10.1074/jbc.274.48.34277</pub-id></element-citation></ref>
<ref id="b25-mmr-15-06-4280"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>DQ</given-names></name></person-group><article-title>Functional switching of ATM: Sensor of DNA damage in proliferating cells and mediator of Akt survival signal in post-mitotic human neuron-like cells</article-title><source>Chin J Cancer</source><volume>31</volume><fpage>364</fpage><lpage>372</lpage><year>2012</year><pub-id pub-id-type="doi">10.5732/cjc.012.10086</pub-id><pub-id pub-id-type="pmcid">3777513</pub-id></element-citation></ref>
<ref id="b26-mmr-15-06-4280"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>DQ</given-names></name><name><surname>Halaby</surname><given-names>MJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hibma</surname><given-names>JC</given-names></name><name><surname>Burn</surname><given-names>P</given-names></name></person-group><article-title>Cytoplasmic ATM protein kinase: An emerging therapeutic target for diabetes, cancer and neuronal degeneration</article-title><source>Drug Discov Today</source><volume>16</volume><fpage>332</fpage><lpage>338</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.drudis.2011.02.001</pub-id></element-citation></ref>
<ref id="b27-mmr-15-06-4280"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Ricupero</surname><given-names>CL</given-names></name><name><surname>Hart</surname><given-names>RP</given-names></name><name><surname>Schwartz</surname><given-names>MS</given-names></name><name><surname>Kusnecov</surname><given-names>A</given-names></name><name><surname>Herrup</surname><given-names>K</given-names></name></person-group><article-title>Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia</article-title><source>Nat Med</source><volume>18</volume><fpage>783</fpage><lpage>790</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/nm.2709</pub-id><pub-id pub-id-type="pmcid">3378917</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-15-06-4280" position="float">
<label>Figure 1.</label>
<caption><p>Effect of exposure to H<sub>2</sub>O<sub>2</sub> on Neuro-2a cell viability. Data are expressed as the mean &#x00B1; standard error (n=5). &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01 and &#x002A;&#x002A;&#x002A;P&#x003C;0.001 vs. control.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g00.tif"/>
</fig>
<fig id="f2-mmr-15-06-4280" position="float">
<label>Figure 2.</label>
<caption><p>Effect of PC with H<sub>2</sub>O<sub>2</sub> on Neuro-2a cell viability. Data are expressed as the mean &#x00B1; standard error (n=5). &#x002A;&#x002A;P&#x003C;0.01 vs. control; <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. PC, preconditioning.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g01.tif"/>
</fig>
<fig id="f3-mmr-15-06-4280" position="float">
<label>Figure 3.</label>
<caption><p>Effect of various treatments on apoptosis induced by 12 h exposure to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub> in Neuro-2a cells, assessed by flow cytometry. Data are expressed as the mean &#x00B1; standard error (n=5). &#x002A;&#x002A;P&#x003C;0.01 vs. control; <sup>##</sup>P&#x003C;0.01 vs. PC &#x002B; 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. PI, propidium iodide; PC, preconditioned with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub>; Ku, Ku55933; RNAi, RNA interference with small interfering RNA; RNAi control, control small interfering RNA.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g02.tif"/>
</fig>
<fig id="f4-mmr-15-06-4280" position="float">
<label>Figure 4.</label>
<caption><p>Effect of various treatments on caspase-3 activity in Neuro-2a cells following exposure to 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, as assessed using a colorimetric CaspACE kit. Data are expressed as the mean &#x00B1; standard error (n=5). &#x002A;&#x002A;P&#x003C;0.01 vs. control; <sup>##</sup>P&#x003C;0.01 vs. PC &#x002B; 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. PC, preconditioned with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub>; Ku, Ku55933; RNAi, RNA interference with small interfering RNA; RNAi control, control small interfering RNA.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g03.tif"/>
</fig>
<fig id="f5-mmr-15-06-4280" position="float">
<label>Figure 5.</label>
<caption><p>Effect of various treatments on 8-OHdG levels in Neuro-2a cells, as determined using a 8-OHdG ELISA assay. Data are expressed as the mean &#x00B1; standard error (n=5). &#x002A;&#x002A;P&#x003C;0.01 vs. control; <sup>##</sup>P&#x003C;0.01 vs. PC &#x002B; 600 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. 8-OHdG, 8-hydroxy-2&#x2032;-deoxyguanosine; PC, preconditioned with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub>; Ku, Ku55933; RNAi, RNA interference with small interfering RNA; RNAi control, control small interfering RNA.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g04.tif"/>
</fig>
<fig id="f6-mmr-15-06-4280" position="float">
<label>Figure 6.</label>
<caption><p>Effect of H<sub>2</sub>O<sub>2</sub> preconditioning on p-ATM expression, as determined by western blot analysis. Data are expressed as the mean &#x00B1; standard error (n=3&#x2013;5). &#x002A;&#x002A;P&#x003C;0.01 vs. control. p-, phosphorylated; ATM, ataxia-telangiectasia mutated; PC, preconditioned with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub>.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g05.tif"/>
</fig>
<fig id="f7-mmr-15-06-4280" position="float">
<label>Figure 7.</label>
<caption><p>Effect of H<sub>2</sub>O<sub>2</sub> preconditioning on (A) ATM mRNA and (B) protein expression levels. Data are expressed as the mean &#x00B1; standard error (n=3&#x2013;5). &#x002A;&#x002A;P&#x003C;0.01 vs. control. ATM, ataxia-telangiectasia mutated; PC, preconditioned with 100 &#x00B5;M H<sub>2</sub>O<sub>2</sub>.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g06.tif"/>
</fig>
<fig id="f8-mmr-15-06-4280" position="float">
<label>Figure 8.</label>
<caption><p>ATM protein expression levels are downregulated by RNAi. Data are expressed as the mean &#x00B1; standard error (n=3). &#x002A;&#x002A;P&#x003C;0.01 vs. control. ATM, ataxia-telangiectasia mutated; RNAi, RNA interference with small interfering RNA; RNAi control, control small interfering RNA.</p></caption>
<graphic xlink:href="MMR-15-06-4280-g07.tif"/>
</fig>
</floats-group>
</article>